168 related articles for article (PubMed ID: 38309274)
1. IκBζ is a dual-use coactivator of NF-κB and POU transcription factors.
Alpsoy A; Wu XS; Pal S; Klingbeil O; Kumar P; El Demerdash O; Nalbant B; Vakoc CR
Mol Cell; 2024 Mar; 84(6):1149-1157.e7. PubMed ID: 38309274
[TBL] [Abstract][Full Text] [Related]
2. The Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs.
Kohda A; Yamazaki S; Sumimoto H
J Biol Chem; 2016 Sep; 291(39):20739-52. PubMed ID: 27489104
[TBL] [Abstract][Full Text] [Related]
3. DNA element downstream of the κB site in the Lcn2 promoter is required for transcriptional activation by IκBζ and NF-κB p50.
Kohda A; Yamazaki S; Sumimoto H
Genes Cells; 2014 Aug; 19(8):620-8. PubMed ID: 24948478
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta.
Yamamoto M; Yamazaki S; Uematsu S; Sato S; Hemmi H; Hoshino K; Kaisho T; Kuwata H; Takeuchi O; Takeshige K; Saitoh T; Yamaoka S; Yamamoto N; Yamamoto S; Muta T; Takeda K; Akira S
Nature; 2004 Jul; 430(6996):218-22. PubMed ID: 15241416
[TBL] [Abstract][Full Text] [Related]
5. The Atypical Inhibitor of NF-κB, IκBζ, Controls Macrophage Interleukin-10 Expression.
Hörber S; Hildebrand DG; Lieb WS; Lorscheid S; Hailfinger S; Schulze-Osthoff K; Essmann F
J Biol Chem; 2016 Jun; 291(24):12851-12861. PubMed ID: 27129283
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling-based evaluation of dual function of IκBζ ankyrin repeat domain in toll-like receptor signaling.
Manavalan B; Govindaraj R; Lee G; Choi S
J Mol Recognit; 2011; 24(4):597-607. PubMed ID: 21472811
[TBL] [Abstract][Full Text] [Related]
7. OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain.
Babb R; Cleary MA; Herr W
Mol Cell Biol; 1997 Dec; 17(12):7295-305. PubMed ID: 9372961
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional Coactivator BOB1 (OBF1, OCA-B) Modulates the Specificity of DNA Recognition by the POU-Domain Factors OCT1 and OCT2 in a Monomeric Configuration.
Nazarov IB; Zilov DS; Gordeev MN; Potapenko EV; Yeremenko N; Tomilin AN
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254723
[TBL] [Abstract][Full Text] [Related]
9. Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B.
Cepek KL; Chasman DI; Sharp PA
Genes Dev; 1996 Aug; 10(16):2079-88. PubMed ID: 8769650
[TBL] [Abstract][Full Text] [Related]
10. IκBζ controls NLRP3 inflammasome activation via upregulation of the Nlrp3 gene.
Kim J; Ahn H; Yu S; Ahn JH; Ko HJ; Kweon MN; Hong EJ; An BS; Lee E; Lee GS
Cytokine; 2020 Mar; 127():154983. PubMed ID: 31918161
[TBL] [Abstract][Full Text] [Related]
11. The Oct1 homolog Nubbin is a repressor of NF-κB-dependent immune gene expression that increases the tolerance to gut microbiota.
Dantoft W; Davis MM; Lindvall JM; Tang X; Uvell H; Junell A; Beskow A; Engström Y
BMC Biol; 2013 Sep; 11():99. PubMed ID: 24010524
[TBL] [Abstract][Full Text] [Related]
12. Induction of IκBζ Augments Cytokine and Chemokine Production by IL-33 in Mast Cells.
Ohto-Ozaki H; Hayakawa M; Kamoshita N; Maruyama T; Tominaga SI; Ohmori T
J Immunol; 2020 Apr; 204(8):2033-2042. PubMed ID: 32144162
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of IκBζ in inflammation: Emphasis on psoriasis.
Gautam P; Maenner S; Cailotto F; Reboul P; Labialle S; Jouzeau JY; Bourgaud F; Moulin D
Clin Transl Med; 2022 Oct; 12(10):e1032. PubMed ID: 36245291
[TBL] [Abstract][Full Text] [Related]
14. IκBζ is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes.
Müller A; Hennig A; Lorscheid S; Grondona P; Schulze-Osthoff K; Hailfinger S; Kramer D
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10088-10093. PubMed ID: 30224457
[TBL] [Abstract][Full Text] [Related]
15. IκBζ is a transcriptional key regulator of CCL2/MCP-1.
Hildebrand DG; Alexander E; Hörber S; Lehle S; Obermayer K; Münck NA; Rothfuss O; Frick JS; Morimatsu M; Schmitz I; Roth J; Ehrchen JM; Essmann F; Schulze-Osthoff K
J Immunol; 2013 May; 190(9):4812-20. PubMed ID: 23547114
[TBL] [Abstract][Full Text] [Related]
16. The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP.
Zwilling S; Annweiler A; Wirth T
Nucleic Acids Res; 1994 May; 22(9):1655-62. PubMed ID: 8202368
[TBL] [Abstract][Full Text] [Related]
17. X-ray Crystallographic Study of Preferred Spacing by the NF-κB p50 Homodimer on κB DNA.
Zhu N; Mealka M; Mitchel S; Milani C; Acuña LM; Rogers E; Lahana AN; Huxford T
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759710
[TBL] [Abstract][Full Text] [Related]
18. IκBζ is a key player in the antipsoriatic effects of secukinumab.
Bertelsen T; Ljungberg C; Litman T; Huppertz C; Hennze R; Rønholt K; Iversen L; Johansen C
J Allergy Clin Immunol; 2020 Jan; 145(1):379-390. PubMed ID: 31622687
[TBL] [Abstract][Full Text] [Related]
19. OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage.
Wu XS; He XY; Ipsaro JJ; Huang YH; Preall JB; Ng D; Shue YT; Sage J; Egeblad M; Joshua-Tor L; Vakoc CR
Nature; 2022 Jul; 607(7917):169-175. PubMed ID: 35576971
[TBL] [Abstract][Full Text] [Related]
20. The human IL-17A/F heterodimer regulates psoriasis-associated genes through IκBζ.
Bertelsen T; Iversen L; Johansen C
Exp Dermatol; 2018 Sep; 27(9):1048-1052. PubMed ID: 29938836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]